Avesi Partners-backed Danforth Health acquires rare disease consultancy AmbitObjectivity score: 40 out of 100.40Objectivity100Quantum Electrodynamics reading levelChimera readability score 100 out of 100, Quantum Electrodynamics reading level.— Read AnalysisAmbit RD, founded to help biopharma companies navigate commercial challenges in rare and specialty disease markets, brings AI-powered patient identification and analytics tools to Danforth's platform.0 Comments